AI Tool Improves Prediction of Cancer Immunotherapy Drug Response

Researchers have developed an artificial intelligence tool that can better predict which cancer patients will respond to immune checkpoint inhibitor (ICI) drugs, a class of immunotherapy medications that have transformed cancer treatment for some patients. While these drugs can cure some cancers or convert deadly diseases into manageable chronic conditions, they only work for a subset of patients, with little understanding of why. This AI advancement addresses a critical knowledge gap that has negatively impacted patient outcomes, clinical trial recruitment, and the development of new therapeutic approaches. The tool could help oncologists identify which patients are most likely to benefit from these expensive treatments, potentially improving treatment selection and reducing unnecessary side effects for non-responders.